Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.41 USD | -4.87% | -5.96% | +32.69% |
May. 15 | Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 | MT |
May. 14 | Transcript : Daré Bioscience, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.69% | 41.45M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.40% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- DARE Stock
- News Daré Bioscience, Inc.
- Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3